- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00942045
Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)
January 7, 2014 updated by: NuVasive
Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF): Evaluation of Radiographic and Patient Outcomes
This is a prospective, non-randomized multi-center study to compare the use of Osteocel Plus in subjects who receive ACDF surgery at one or two levels.
These subjects will present with degenerative conditions in the cervical spine that are amenable to surgical treatment and will be screened prior to study enrollment.
Subjects will receive Osteocel Plus, without any other biologic product, during their ACDF operation.
The ACDF procedure will be conducted with a radiolucent graft containment device such that progression of fusion can be adequately assessed via radiograph.
Subjects will be followed for 24-months following surgery to determine the number of study subjects that are solidly fused at or before 24 months postoperatively, and to determine the mean time to fusion.
This data will be compared to published and/or retrospective data for autograft, synthetic ceramics and Bone Morphogenetic Protein (BMP).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 175 subjects will be selected for enrollment in this study from multiple centers.
The subjects will have degenerative conditions in the cervical spine and will be undergoing ACDF surgery as treatment at one or two levels.
The following eligibility criteria are designed to select subjects for whom protocol treatment is considered appropriate.
All relevant medical and non-medical conditions should be taken into consideration when deciding whether this protocol is suitable for a particular subject.
Study Type
Observational
Enrollment (Actual)
182
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92037
- Shiley Center for Orthopaedic, Scripps Green Hospital
-
Redwood City, California, United States, 94063
- Stanford University
-
San Diego, California, United States, 92103
- UCSD Department of Orthpaedic Surgery, UCSD Medical Center
-
Santa Monica, California, United States, 90404
- The Spine Institute, St. John's Health Center
-
-
Florida
-
Tampa, Florida, United States, 33606
- University of South Florida Department of Neurosurgery, Tampa General Hospital
-
-
Georgia
-
Marietta, Georgia, United States, 30060
- Pinnacle Orthopaedics, Wellstone Kennestone Hospital
-
-
Illinois
-
Joliet, Illinois, United States, 60435
- Hinsdale Orthopaedic Associates, Provena Saint Joseph Medical Center
-
-
Indiana
-
Indianopolis, Indiana, United States, 46219
- Indiana Center for NeuroSurgery, Indiana Surgery Center East
-
-
Missouri
-
Columbia, Missouri, United States, 65201
- Columbia Orthopaedic Group, Boone Hospital Center
-
-
Montana
-
Billings, Montana, United States, 59101
- NWREI (for Ortho Montana)
-
-
New York
-
Lockport, New York, United States, 14094
- Buffalo Spine Surgery, Kenmore Mercy
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University Medical Center
-
-
Ohio
-
Chillicothe, Ohio, United States, 45601
- The Center for Advanced Orthopaedics, Adena Bone and Joint Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19106
- University of Pennsylvania
-
-
Texas
-
Southlake, Texas, United States, 76092
- Spine Team Texas, Texas Health Harris Methodist Hospital Southlake
-
-
Virginia
-
Winchester, Virginia, United States, 22601
- Winchester Medical Center
-
-
Washington
-
Seattle, Washington, United States, 98122
- Swedish Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Existing clinic patients
Description
Inclusion Criteria:
- Persistent neck and/or arm pain unresponsive to conservative treatment for at least 6 weeks, unless clinically indicated sooner
- Indicated for anterior fusion at one or two contiguous cervical levels (C3 to T1)
- Objective evidence of primary diagnosis must be confirmed by appropriate imaging studies
- 18-70 years of age at the date of written informed consent
- Able to undergo surgery based on physical exam, medical history and surgeon judgment
- Expected to survive at least 2 years beyond surgery
- Willing and able to return for post-treatment exams according to the follow-up called for in the protocol
- Signed and dated Informed Consent Form
Exclusion Criteria:
- Patient has a mental or physical condition that would limit the ability to comply with study requirements
- Cervical spine abnormality requiring treatment at more than two levels
- Systemic or local infection; active or latent
- Previous failed fusion at the operative level
- Diseases that significantly inhibit bone healing (osteoporosis, metabolic bone disease, uncontrolled diabetes, dialysis dependent renal failure, symptomatic liver disease)
- Undergoing chemotherapy or radiation treatment, or chronic use of steroids (defined as more than 6 weeks of steroid use within 12 months of surgery, other than episodic use or inhaled corticosteroids)
- Pregnant, or plans to become pregnant during the study
- Subject is a prisoner
- Involvement in active litigation relating to the spine (worker's compensation claim is allowed if it is not contended)
- A significant general illness (e.g., HIV, active metastatic cancer of any type) is present; subject is immunocompromised or is being treated with immunosuppressive agents that decrease the probability of survival to the two-year endpoint of the study
- Participating in another clinical study at any time during the study participation that would confound study data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the fusion rates of Osteocel Plus in one or two level(s) for ACDF subjects.
Time Frame: from pre-op to 24-month follow-up
|
from pre-op to 24-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate the rate of complications for Osteocel Plus and compare to published and/or retrospective data for autograft or bone morphogenetic protein (BMP).
Time Frame: from pre-op to 24-month follow-up
|
from pre-op to 24-month follow-up
|
To evaluate and compare each outcome with respect to surgical time and blood loss.
Time Frame: from pre-op to 24-month follow-up
|
from pre-op to 24-month follow-up
|
To evaluate and compare radiographic outcome with respect to clinical outcome (function and pain).
Time Frame: from pre-op to 24-month post-op
|
from pre-op to 24-month post-op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kelli Howell, MS, NuVasive
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
October 1, 2012
Study Registration Dates
First Submitted
July 16, 2009
First Submitted That Met QC Criteria
July 17, 2009
First Posted (Estimate)
July 20, 2009
Study Record Updates
Last Update Posted (Estimate)
January 8, 2014
Last Update Submitted That Met QC Criteria
January 7, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUVA.OC.0802
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease in Cervical Spine
-
Texas Woman's UniversityTexas Society of Allied Health Professions; Texas Spine and Joint HospitalCompletedCervical Spine Degenerative Disc Disease | Fusion of Spine, Cervical RegionUnited States
-
Duke UniversityWithdrawnSurgery | Degenerative Disc Disease | Cervical Spine Disc Disease | Fusion of Spine
-
Rush University Medical CenterWithdrawnDegenerative Disc Disease | Cervical Spine DegenerationUnited States
-
NuVasiveEnrolling by invitationDegenerative Disc Disease | Craniocervical Injuries | Cervical Radiculopathy | Cervical Disc Disease | Cervical Fusion | Cervical Spine Disease | Cervical Myelopathy | Cervical Instabilities Spine | Thoracic InjuryUnited States
-
Medtronic Spinal and BiologicsCompletedDegenerative Cervical Disc DiseaseSaudi Arabia, Greece, Serbia, Hungary, Czech Republic, Kuwait, Poland, Slovakia
-
Assiut UniversityNot yet recruiting
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Vanderbilt University Medical CenterCompletedSpinal Fusion | Cervical Spine Degenerative DiseaseUnited States
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
Clinical Trials on Biologic - Osteocel Plus
-
NuVasiveCompletedBack Pain | Degenerative Disc DiseaseUnited States
-
NuVasiveCompletedDegenerative Disc Disease, LumbarUnited States
-
NuVasiveCompletedDegenerative Disc DiseaseUnited States
-
NuVasiveCompleted
-
University of CalgaryMedtronicRecruiting
-
DermTechRecruitingAtopic DermatitisUnited States
-
University of Missouri-ColumbiaCompletedKnee Osteoarthritis | Post-traumatic OsteoarthritisUnited States
-
Miromatrix Medical Inc.Completed
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Psoriasis Treatment Center of Central New JerseyJanssen Scientific Affairs, LLCCompleted